Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 6,109 shares of the company’s stock after purchasing an additional 412 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Henry Schein were worth $423,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. CIBC Asset Management Inc grew its position in Henry Schein by 7.0% during the 3rd quarter. CIBC Asset Management Inc now owns 17,680 shares of the company’s stock worth $1,289,000 after purchasing an additional 1,162 shares during the last quarter. Natixis Advisors LLC grew its holdings in shares of Henry Schein by 18.8% during the third quarter. Natixis Advisors LLC now owns 81,877 shares of the company’s stock valued at $5,969,000 after buying an additional 12,930 shares during the last quarter. Thrivent Financial for Lutherans increased its position in shares of Henry Schein by 1,848.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 105,415 shares of the company’s stock valued at $7,685,000 after acquiring an additional 100,006 shares during the period. Pathstone Holdings LLC raised its stake in Henry Schein by 3.1% in the 3rd quarter. Pathstone Holdings LLC now owns 24,028 shares of the company’s stock worth $1,752,000 after acquiring an additional 732 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Henry Schein during the 3rd quarter worth about $515,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Up 0.3 %

HSIC opened at $72.00 on Wednesday. The company has a fifty day moving average of $74.85 and a two-hundred day moving average of $72.63. The stock has a market capitalization of $8.94 billion, a price-to-earnings ratio of 29.63, a PEG ratio of 2.13 and a beta of 0.90. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.66 EPS. On average, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Jefferies Financial Group increased their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.